Quick answer
Emergency healthcare procurement refers to the use of accelerated or direct award procedures by health authorities and governments to purchase medical goods and services rapidly during declared public health emergencies, drawing on the extreme urgency exceptions in EU Directive 2014/24/EU and equivalent national frameworks.
Emergency healthcare procurement became a defining challenge for health systems across Europe during the COVID-19 pandemic, when demand for personal protective equipment, ventilators, vaccines, and diagnostics surged to levels that normal competitive tendering could not accommodate. The legal frameworks for emergency procurement existed before 2020 but were stress-tested at a scale never previously encountered. Understanding these frameworks is essential for suppliers seeking to participate in health emergency markets and for contracting authorities managing procurement in crisis conditions.
What is Emergency Healthcare Procurement?
Emergency healthcare procurement draws on specific flexibilities within EU Directive 2014/24/EU and equivalent national frameworks.
Extreme urgency grounds (negotiated procedure without prior publication). Article 32(2)(c) of Directive 2014/24/EU permits contracting authorities to use negotiated procedure without prior publication where extreme urgency, brought about by unforeseeable events not attributable to the contracting authority, makes it impossible to comply with normal time limits. This is the primary legal basis for emergency direct awards. The grounds are strict: the urgency must be genuine and unforeseeable, not the result of poor planning.
Accelerated procedures. Even where the full procedure is required, Article 27(3) (open procedure) and Article 28(6) (restricted procedure) of Directive 2014/24/EU allow time limits to be reduced significantly where duly justified urgency makes the standard periods impracticable. Accelerated open procedures can reduce the minimum response period from 35 days to 15 days.
EU joint procurement. The EU operates a joint procurement mechanism for medical countermeasures under Decision 1082/2013/EU, allowing member states to participate in joint tenders coordinated by the European Commission. This was used extensively during COVID-19 for vaccines and antiviral medicines. HERA (Health Emergency Preparedness and Response Authority), established in 2021, now coordinates EU-level procurement for medical countermeasures on a standing basis.
UK provisions. In the UK, the Procurement Act 2023 includes a defence and security exception and provisions for extreme urgency that mirror the EU framework. NHS and local authority bodies may use negotiated procedure without prior publication on urgency grounds, subject to the same conditions of genuine unforeseeable circumstances. The UK also maintains emergency stockpiling arrangements for certain healthcare supply chain categories through NHS Supply Chain.
Why it matters for bidders
Suppliers who can demonstrate rapid deployment capability, surge capacity, and resilient supply chains are well-positioned for emergency procurement opportunities. However, the extreme urgency exception is often misapplied: it does not create a general exemption from procurement law, and contracting authorities that use it improperly face legal challenge and audit scrutiny. Suppliers should expect contracts awarded under urgency grounds to be published promptly after award and subject to ex-post scrutiny.
For pharmaceutical procurement and medical devices procurement in particular, maintaining up-to-date CE marking, UKCA marking, and marketing authorisations is a prerequisite for emergency supply, as there is typically insufficient time to complete regulatory approvals during a crisis.
Example
During a regional outbreak of a severe respiratory illness, a European health ministry invokes the extreme urgency grounds under Article 32(2)(c) of Directive 2014/24/EU to directly award a 90-day contract for FFP3 respirators to a qualified supplier with confirmed domestic production capacity. The contract is published as an award notice on TED within 30 days. The ministry documents its assessment of unforeseeable urgency and the impossibility of running a competitive process within the required timeframe.
Frequently Asked Questions
Can contracting authorities use emergency procurement grounds for slow-moving crises?
No. The extreme urgency grounds require that the events causing urgency are both unforeseeable and not attributable to the contracting authority. A slowly developing health situation that was foreseeable does not qualify. Contracting authorities that misapply urgency grounds risk challenge, audit findings, and in some EU member states, financial corrections on EU-funded contracts.
How long can emergency contracts last?
There is no prescribed maximum duration under the extreme urgency grounds, but the contract must cover only the period strictly necessary to address the emergency. Contracting authorities are expected to run a competitive process as soon as circumstances permit. Repeatedly extending or renewing emergency direct awards without running a competition is challengeable under EU procurement principles.
What transparency obligations apply to emergency awards?
Both EU and UK rules require publication of a contract award notice after an emergency direct award. Under EU Directive 2014/24/EU, this must occur within 30 days of the award. Under the UK Procurement Act 2023, equivalent transparency notices are required. The ex-post transparency requirement is designed to enable scrutiny even where prior advertising was impossible.
How Bidovate helps
Bidovate puts Emergency Healthcare Procurement to work inside your capture and proposal workflow.
Tender discoverySee Bidovate in action
Book a demo and we will show you the platform using your actual contract data.
Related terms
Healthcare Supply Chain Procurement
Healthcare supply chain procurement covers the purchasing of clinical and non-clinical goods that flow through hospitals, clinics, and care settings, including consumables, personal protective equipment, surgical instruments, and logistics services, typically managed through central frameworks and catalogues to achieve economies of scale.
ViewPharmaceutical Procurement
Pharmaceutical procurement covers the purchasing of medicines, biologics, and advanced therapy medicinal products by hospitals, health authorities, and national agencies, involving unique considerations around patent protection, generic substitution, joint EU procurement, and regulatory compliance that distinguish it from standard public procurement.
ViewMedical Devices Procurement
Medical devices procurement covers the purchasing of instruments, equipment, implants, software, and diagnostic products by hospitals and health authorities, requiring compliance with both EU Medical Devices Regulation (MDR 2017/745) or UK UKCA marking requirements and standard public procurement rules for above-threshold contracts.
ViewNHS Procurement (UK)
NHS procurement encompasses all purchasing activity by National Health Service bodies in the UK, covering clinical supplies, pharmaceuticals, medical devices, and health services, governed by a combination of the UK Procurement Act 2023, the Provider Selection Regime, and NHS Supply Chain frameworks.
ViewLight-Touch Regime (Healthcare)
The light-touch regime is a simplified procurement framework under Directive 2014/24/EU and the UK Procurement Act 2023 that applies to health, social, and certain other services listed in Annex XIV, requiring publication and adherence to core principles but allowing contracting authorities much greater procedural flexibility than standard procurement.
View